These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 24275132)

  • 1. CT screening for lung cancer: countdown to implementation.
    Field JK; Hansell DM; Duffy SW; Baldwin DR
    Lancet Oncol; 2013 Dec; 14(13):e591-600. PubMed ID: 24275132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung cancer screening.
    Tanoue LT; Tanner NT; Gould MK; Silvestri GA
    Am J Respir Crit Care Med; 2015 Jan; 191(1):19-33. PubMed ID: 25369325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for lung cancer with low-dose computed tomography: a systematic review to update the US Preventive services task force recommendation.
    Humphrey LL; Deffebach M; Pappas M; Baumann C; Artis K; Mitchell JP; Zakher B; Fu R; Slatore CG
    Ann Intern Med; 2013 Sep; 159(6):411-420. PubMed ID: 23897166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biennial lung cancer screening in Canada with smoking cessation-outcomes and cost-effectiveness.
    Goffin JR; Flanagan WM; Miller AB; Fitzgerald NR; Memon S; Wolfson MC; Evans WK
    Lung Cancer; 2016 Nov; 101():98-103. PubMed ID: 27794416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for Lung Cancer With Low-Dose Computed Tomography: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Jonas DE; Reuland DS; Reddy SM; Nagle M; Clark SD; Weber RP; Enyioha C; Malo TL; Brenner AT; Armstrong C; Coker-Schwimmer M; Middleton JC; Voisin C; Harris RP
    JAMA; 2021 Mar; 325(10):971-987. PubMed ID: 33687468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose computed tomography screening for lung cancer: how strong is the evidence?
    Woolf SH; Harris RP; Campos-Outcalt D
    JAMA Intern Med; 2014 Dec; 174(12):2019-22. PubMed ID: 25317533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical effectiveness and cost-effectiveness of computed tomography screening for lung cancer: systematic reviews.
    Black C; Bagust A; Boland A; Walker S; McLeod C; De Verteuil R; Ayres J; Bain L; Thomas S; Godden D; Waugh N
    Health Technol Assess; 2006 Jan; 10(3):iii-iv, ix-x, 1-90. PubMed ID: 16409881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung cancer screening: did we really need a randomized controlled trial?
    Al-Ayoubi AM; Flores RM
    Eur J Cardiothorac Surg; 2016 Jul; 50(1):29-33. PubMed ID: 27005972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computed tomography screening for lung cancer in the National Lung Screening Trial: a cost-effectiveness analysis.
    Black WC
    J Thorac Imaging; 2015 Mar; 30(2):79-87. PubMed ID: 25635704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CT screening for lung cancer: Are we ready to implement in Europe?
    Balata H; Evison M; Sharman A; Crosbie P; Booton R
    Lung Cancer; 2019 Aug; 134():25-33. PubMed ID: 31319989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current estimate of costs of lung cancer screening in the United States.
    Mauchley DC; Mitchell JD
    Thorac Surg Clin; 2015 May; 25(2):205-15. PubMed ID: 25901564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement.
    Moyer VA;
    Ann Intern Med; 2014 Mar; 160(5):330-8. PubMed ID: 24378917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical impact and cost-effectiveness of integrating smoking cessation into lung cancer screening: a microsimulation model.
    Evans WK; Gauvreau CL; Flanagan WM; Memon S; Yong JHE; Goffin JR; Fitzgerald NR; Wolfson M; Miller AB
    CMAJ Open; 2020; 8(3):E585-E592. PubMed ID: 32963023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-Effectiveness Analysis of Lung Cancer Screening in the United States: A Comparative Modeling Study.
    Criss SD; Cao P; Bastani M; Ten Haaf K; Chen Y; Sheehan DF; Blom EF; Toumazis I; Jeon J; de Koning HJ; Plevritis SK; Meza R; Kong CY
    Ann Intern Med; 2019 Dec; 171(11):796-804. PubMed ID: 31683314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CT screening for lung cancer: Is the evidence strong enough?
    Field JK; Devaraj A; Duffy SW; Baldwin DR
    Lung Cancer; 2016 Jan; 91():29-35. PubMed ID: 26711931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung cancer screening gets risk-specific.
    Peres J
    J Natl Cancer Inst; 2013 Jan; 105(1):1-2. PubMed ID: 23257155
    [No Abstract]   [Full Text] [Related]  

  • 17. Issues with implementing a high-quality lung cancer screening program.
    Mulshine JL; D'Amico TA
    CA Cancer J Clin; 2014; 64(5):352-63. PubMed ID: 24976072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung cancer screening-low dose CT for lung cancer screening: recent trial results and next steps.
    O'Dowd EL; Baldwin DR
    Br J Radiol; 2018 Oct; 91(1090):20170460. PubMed ID: 28749712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of CT screening in the National Lung Screening Trial.
    Black WC; Gareen IF; Soneji SS; Sicks JD; Keeler EB; Aberle DR; Naeim A; Church TR; Silvestri GA; Gorelick J; Gatsonis C;
    N Engl J Med; 2014 Nov; 371(19):1793-802. PubMed ID: 25372087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is the Optimum Screening Strategy for the Early Detection of Lung Cancer.
    Baldwin DR; Callister ME
    Clin Oncol (R Coll Radiol); 2016 Nov; 28(11):672-681. PubMed ID: 27544425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.